0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccines and Parasiticides for Pet Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-29V12645
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Vaccines and Parasiticides for Pet Market Research Report 2022
BUY CHAPTERS

Global Vaccines and Parasiticides for Pet Market Research Report 2025

Code: QYRE-Auto-29V12645
Report
February 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vaccines and Parasiticides for Pet Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

Vaccines and Parasiticides for Pet Market

Vaccines and Parasiticides for Pet Market

The global market for Vaccines and Parasiticides for Pet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 500%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccines and Parasiticides for Pet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines and Parasiticides for Pet.
The Vaccines and Parasiticides for Pet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines and Parasiticides for Pet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines and Parasiticides for Pet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vaccines and Parasiticides for Pet Market Report

Report Metric Details
Report Name Vaccines and Parasiticides for Pet Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
Segment by Type
  • Parasiticides
  • Vaccines
Segment by Application
  • Dog
  • Cat
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Elanco, VCA Animal Hospitals, Banfield, CVS Group, MedVet, Petco, Puppy Town Animal Hospital, PetIQ, Beloved Pet Hospital, Vegreville Veterinary Clinic, Boehringer Ingelheim, Zoetis, Bayer, Merck, Vetoquinol, Bimeda Animal Health, Virbac, Hvsen Biotechnology, Ceva Corporate
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaccines and Parasiticides for Pet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaccines and Parasiticides for Pet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vaccines and Parasiticides for Pet Market report?

Ans: The main players in the Vaccines and Parasiticides for Pet Market are Elanco, VCA Animal Hospitals, Banfield, CVS Group, MedVet, Petco, Puppy Town Animal Hospital, PetIQ, Beloved Pet Hospital, Vegreville Veterinary Clinic, Boehringer Ingelheim, Zoetis, Bayer, Merck, Vetoquinol, Bimeda Animal Health, Virbac, Hvsen Biotechnology, Ceva Corporate

What are the Application segmentation covered in the Vaccines and Parasiticides for Pet Market report?

Ans: The Applications covered in the Vaccines and Parasiticides for Pet Market report are Dog, Cat, Other

What are the Type segmentation covered in the Vaccines and Parasiticides for Pet Market report?

Ans: The Types covered in the Vaccines and Parasiticides for Pet Market report are Parasiticides, Vaccines

Recommended Reports

Veterinary Healthcare

Animal Health Markets

Pet Nutrition & Products

1 Vaccines and Parasiticides for Pet Market Overview
1.1 Product Definition
1.2 Vaccines and Parasiticides for Pet by Type
1.2.1 Global Vaccines and Parasiticides for Pet Market Value Comparison by Type (2024 VS 2031)
1.2.2 Parasiticides
1.2.3 Vaccines
1.3 Vaccines and Parasiticides for Pet by Application
1.3.1 Global Vaccines and Parasiticides for Pet Market Value by Application (2024 VS 2031)
1.3.2 Dog
1.3.3 Cat
1.3.4 Other
1.4 Global Vaccines and Parasiticides for Pet Market Size Estimates and Forecasts
1.4.1 Global Vaccines and Parasiticides for Pet Revenue 2020-2031
1.4.2 Global Vaccines and Parasiticides for Pet Sales 2020-2031
1.4.3 Global Vaccines and Parasiticides for Pet Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccines and Parasiticides for Pet Market Competition by Manufacturers
2.1 Global Vaccines and Parasiticides for Pet Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccines and Parasiticides for Pet Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccines and Parasiticides for Pet Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccines and Parasiticides for Pet, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccines and Parasiticides for Pet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccines and Parasiticides for Pet, Product Type & Application
2.7 Global Key Manufacturers of Vaccines and Parasiticides for Pet, Date of Enter into This Industry
2.8 Global Vaccines and Parasiticides for Pet Market Competitive Situation and Trends
2.8.1 Global Vaccines and Parasiticides for Pet Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccines and Parasiticides for Pet Players Market Share by Revenue
2.8.3 Global Vaccines and Parasiticides for Pet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccines and Parasiticides for Pet Market Scenario by Region
3.1 Global Vaccines and Parasiticides for Pet Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccines and Parasiticides for Pet Sales by Region: 2020-2031
3.2.1 Global Vaccines and Parasiticides for Pet Sales by Region: 2020-2025
3.2.2 Global Vaccines and Parasiticides for Pet Sales by Region: 2026-2031
3.3 Global Vaccines and Parasiticides for Pet Revenue by Region: 2020-2031
3.3.1 Global Vaccines and Parasiticides for Pet Revenue by Region: 2020-2025
3.3.2 Global Vaccines and Parasiticides for Pet Revenue by Region: 2026-2031
3.4 North America Vaccines and Parasiticides for Pet Market Facts & Figures by Country
3.4.1 North America Vaccines and Parasiticides for Pet Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccines and Parasiticides for Pet Sales by Country (2020-2031)
3.4.3 North America Vaccines and Parasiticides for Pet Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccines and Parasiticides for Pet Market Facts & Figures by Country
3.5.1 Europe Vaccines and Parasiticides for Pet Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccines and Parasiticides for Pet Sales by Country (2020-2031)
3.5.3 Europe Vaccines and Parasiticides for Pet Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines and Parasiticides for Pet Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccines and Parasiticides for Pet Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccines and Parasiticides for Pet Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccines and Parasiticides for Pet Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccines and Parasiticides for Pet Market Facts & Figures by Country
3.7.1 Latin America Vaccines and Parasiticides for Pet Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccines and Parasiticides for Pet Sales by Country (2020-2031)
3.7.3 Latin America Vaccines and Parasiticides for Pet Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccines and Parasiticides for Pet Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines and Parasiticides for Pet Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccines and Parasiticides for Pet Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccines and Parasiticides for Pet Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccines and Parasiticides for Pet Sales by Type (2020-2031)
4.1.1 Global Vaccines and Parasiticides for Pet Sales by Type (2020-2025)
4.1.2 Global Vaccines and Parasiticides for Pet Sales by Type (2026-2031)
4.1.3 Global Vaccines and Parasiticides for Pet Sales Market Share by Type (2020-2031)
4.2 Global Vaccines and Parasiticides for Pet Revenue by Type (2020-2031)
4.2.1 Global Vaccines and Parasiticides for Pet Revenue by Type (2020-2025)
4.2.2 Global Vaccines and Parasiticides for Pet Revenue by Type (2026-2031)
4.2.3 Global Vaccines and Parasiticides for Pet Revenue Market Share by Type (2020-2031)
4.3 Global Vaccines and Parasiticides for Pet Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccines and Parasiticides for Pet Sales by Application (2020-2031)
5.1.1 Global Vaccines and Parasiticides for Pet Sales by Application (2020-2025)
5.1.2 Global Vaccines and Parasiticides for Pet Sales by Application (2026-2031)
5.1.3 Global Vaccines and Parasiticides for Pet Sales Market Share by Application (2020-2031)
5.2 Global Vaccines and Parasiticides for Pet Revenue by Application (2020-2031)
5.2.1 Global Vaccines and Parasiticides for Pet Revenue by Application (2020-2025)
5.2.2 Global Vaccines and Parasiticides for Pet Revenue by Application (2026-2031)
5.2.3 Global Vaccines and Parasiticides for Pet Revenue Market Share by Application (2020-2031)
5.3 Global Vaccines and Parasiticides for Pet Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Elanco
6.1.1 Elanco Company Information
6.1.2 Elanco Description and Business Overview
6.1.3 Elanco Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Elanco Vaccines and Parasiticides for Pet Product Portfolio
6.1.5 Elanco Recent Developments/Updates
6.2 VCA Animal Hospitals
6.2.1 VCA Animal Hospitals Company Information
6.2.2 VCA Animal Hospitals Description and Business Overview
6.2.3 VCA Animal Hospitals Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.2.4 VCA Animal Hospitals Vaccines and Parasiticides for Pet Product Portfolio
6.2.5 VCA Animal Hospitals Recent Developments/Updates
6.3 Banfield
6.3.1 Banfield Company Information
6.3.2 Banfield Description and Business Overview
6.3.3 Banfield Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Banfield Vaccines and Parasiticides for Pet Product Portfolio
6.3.5 Banfield Recent Developments/Updates
6.4 CVS Group
6.4.1 CVS Group Company Information
6.4.2 CVS Group Description and Business Overview
6.4.3 CVS Group Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CVS Group Vaccines and Parasiticides for Pet Product Portfolio
6.4.5 CVS Group Recent Developments/Updates
6.5 MedVet
6.5.1 MedVet Company Information
6.5.2 MedVet Description and Business Overview
6.5.3 MedVet Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MedVet Vaccines and Parasiticides for Pet Product Portfolio
6.5.5 MedVet Recent Developments/Updates
6.6 Petco
6.6.1 Petco Company Information
6.6.2 Petco Description and Business Overview
6.6.3 Petco Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Petco Vaccines and Parasiticides for Pet Product Portfolio
6.6.5 Petco Recent Developments/Updates
6.7 Puppy Town Animal Hospital
6.7.1 Puppy Town Animal Hospital Company Information
6.7.2 Puppy Town Animal Hospital Description and Business Overview
6.7.3 Puppy Town Animal Hospital Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Puppy Town Animal Hospital Vaccines and Parasiticides for Pet Product Portfolio
6.7.5 Puppy Town Animal Hospital Recent Developments/Updates
6.8 PetIQ
6.8.1 PetIQ Company Information
6.8.2 PetIQ Description and Business Overview
6.8.3 PetIQ Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.8.4 PetIQ Vaccines and Parasiticides for Pet Product Portfolio
6.8.5 PetIQ Recent Developments/Updates
6.9 Beloved Pet Hospital
6.9.1 Beloved Pet Hospital Company Information
6.9.2 Beloved Pet Hospital Description and Business Overview
6.9.3 Beloved Pet Hospital Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Beloved Pet Hospital Vaccines and Parasiticides for Pet Product Portfolio
6.9.5 Beloved Pet Hospital Recent Developments/Updates
6.10 Vegreville Veterinary Clinic
6.10.1 Vegreville Veterinary Clinic Company Information
6.10.2 Vegreville Veterinary Clinic Description and Business Overview
6.10.3 Vegreville Veterinary Clinic Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vegreville Veterinary Clinic Vaccines and Parasiticides for Pet Product Portfolio
6.10.5 Vegreville Veterinary Clinic Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Company Information
6.11.2 Boehringer Ingelheim Description and Business Overview
6.11.3 Boehringer Ingelheim Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Boehringer Ingelheim Vaccines and Parasiticides for Pet Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Zoetis
6.12.1 Zoetis Company Information
6.12.2 Zoetis Description and Business Overview
6.12.3 Zoetis Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zoetis Vaccines and Parasiticides for Pet Product Portfolio
6.12.5 Zoetis Recent Developments/Updates
6.13 Bayer
6.13.1 Bayer Company Information
6.13.2 Bayer Description and Business Overview
6.13.3 Bayer Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Bayer Vaccines and Parasiticides for Pet Product Portfolio
6.13.5 Bayer Recent Developments/Updates
6.14 Merck
6.14.1 Merck Company Information
6.14.2 Merck Description and Business Overview
6.14.3 Merck Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Merck Vaccines and Parasiticides for Pet Product Portfolio
6.14.5 Merck Recent Developments/Updates
6.15 Vetoquinol
6.15.1 Vetoquinol Company Information
6.15.2 Vetoquinol Description and Business Overview
6.15.3 Vetoquinol Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Vetoquinol Vaccines and Parasiticides for Pet Product Portfolio
6.15.5 Vetoquinol Recent Developments/Updates
6.16 Bimeda Animal Health
6.16.1 Bimeda Animal Health Company Information
6.16.2 Bimeda Animal Health Description and Business Overview
6.16.3 Bimeda Animal Health Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bimeda Animal Health Vaccines and Parasiticides for Pet Product Portfolio
6.16.5 Bimeda Animal Health Recent Developments/Updates
6.17 Virbac
6.17.1 Virbac Company Information
6.17.2 Virbac Description and Business Overview
6.17.3 Virbac Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Virbac Vaccines and Parasiticides for Pet Product Portfolio
6.17.5 Virbac Recent Developments/Updates
6.18 Hvsen Biotechnology
6.18.1 Hvsen Biotechnology Company Information
6.18.2 Hvsen Biotechnology Description and Business Overview
6.18.3 Hvsen Biotechnology Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Hvsen Biotechnology Vaccines and Parasiticides for Pet Product Portfolio
6.18.5 Hvsen Biotechnology Recent Developments/Updates
6.19 Ceva Corporate
6.19.1 Ceva Corporate Company Information
6.19.2 Ceva Corporate Description and Business Overview
6.19.3 Ceva Corporate Vaccines and Parasiticides for Pet Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Ceva Corporate Vaccines and Parasiticides for Pet Product Portfolio
6.19.5 Ceva Corporate Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines and Parasiticides for Pet Industry Chain Analysis
7.2 Vaccines and Parasiticides for Pet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines and Parasiticides for Pet Production Mode & Process Analysis
7.4 Vaccines and Parasiticides for Pet Sales and Marketing
7.4.1 Vaccines and Parasiticides for Pet Sales Channels
7.4.2 Vaccines and Parasiticides for Pet Distributors
7.5 Vaccines and Parasiticides for Pet Customer Analysis
8 Vaccines and Parasiticides for Pet Market Dynamics
8.1 Vaccines and Parasiticides for Pet Industry Trends
8.2 Vaccines and Parasiticides for Pet Market Drivers
8.3 Vaccines and Parasiticides for Pet Market Challenges
8.4 Vaccines and Parasiticides for Pet Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Vaccines and Parasiticides for Pet Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vaccines and Parasiticides for Pet Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vaccines and Parasiticides for Pet Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vaccines and Parasiticides for Pet Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Vaccines and Parasiticides for Pet Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vaccines and Parasiticides for Pet Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vaccines and Parasiticides for Pet Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vaccines and Parasiticides for Pet Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vaccines and Parasiticides for Pet, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vaccines and Parasiticides for Pet, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vaccines and Parasiticides for Pet, Product Type & Application
 Table 12. Global Key Manufacturers of Vaccines and Parasiticides for Pet, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vaccines and Parasiticides for Pet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines and Parasiticides for Pet as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vaccines and Parasiticides for Pet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vaccines and Parasiticides for Pet Sales by Region (2020-2025) & (K Units)
 Table 18. Global Vaccines and Parasiticides for Pet Sales Market Share by Region (2020-2025)
 Table 19. Global Vaccines and Parasiticides for Pet Sales by Region (2026-2031) & (K Units)
 Table 20. Global Vaccines and Parasiticides for Pet Sales Market Share by Region (2026-2031)
 Table 21. Global Vaccines and Parasiticides for Pet Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vaccines and Parasiticides for Pet Revenue Market Share by Region (2020-2025)
 Table 23. Global Vaccines and Parasiticides for Pet Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vaccines and Parasiticides for Pet Revenue Market Share by Region (2026-2031)
 Table 25. North America Vaccines and Parasiticides for Pet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vaccines and Parasiticides for Pet Sales by Country (2020-2025) & (K Units)
 Table 27. North America Vaccines and Parasiticides for Pet Sales by Country (2026-2031) & (K Units)
 Table 28. North America Vaccines and Parasiticides for Pet Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vaccines and Parasiticides for Pet Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vaccines and Parasiticides for Pet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vaccines and Parasiticides for Pet Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Vaccines and Parasiticides for Pet Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Vaccines and Parasiticides for Pet Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vaccines and Parasiticides for Pet Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vaccines and Parasiticides for Pet Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vaccines and Parasiticides for Pet Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Vaccines and Parasiticides for Pet Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Vaccines and Parasiticides for Pet Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vaccines and Parasiticides for Pet Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vaccines and Parasiticides for Pet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vaccines and Parasiticides for Pet Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Vaccines and Parasiticides for Pet Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Vaccines and Parasiticides for Pet Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccines and Parasiticides for Pet Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vaccines and Parasiticides for Pet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vaccines and Parasiticides for Pet Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Vaccines and Parasiticides for Pet Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Vaccines and Parasiticides for Pet Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vaccines and Parasiticides for Pet Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vaccines and Parasiticides for Pet Sales (K Units) by Type (2020-2025)
 Table 51. Global Vaccines and Parasiticides for Pet Sales (K Units) by Type (2026-2031)
 Table 52. Global Vaccines and Parasiticides for Pet Sales Market Share by Type (2020-2025)
 Table 53. Global Vaccines and Parasiticides for Pet Sales Market Share by Type (2026-2031)
 Table 54. Global Vaccines and Parasiticides for Pet Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vaccines and Parasiticides for Pet Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vaccines and Parasiticides for Pet Revenue Market Share by Type (2020-2025)
 Table 57. Global Vaccines and Parasiticides for Pet Revenue Market Share by Type (2026-2031)
 Table 58. Global Vaccines and Parasiticides for Pet Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Vaccines and Parasiticides for Pet Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Vaccines and Parasiticides for Pet Sales (K Units) by Application (2020-2025)
 Table 61. Global Vaccines and Parasiticides for Pet Sales (K Units) by Application (2026-2031)
 Table 62. Global Vaccines and Parasiticides for Pet Sales Market Share by Application (2020-2025)
 Table 63. Global Vaccines and Parasiticides for Pet Sales Market Share by Application (2026-2031)
 Table 64. Global Vaccines and Parasiticides for Pet Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vaccines and Parasiticides for Pet Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vaccines and Parasiticides for Pet Revenue Market Share by Application (2020-2025)
 Table 67. Global Vaccines and Parasiticides for Pet Revenue Market Share by Application (2026-2031)
 Table 68. Global Vaccines and Parasiticides for Pet Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Vaccines and Parasiticides for Pet Price (US$/Unit) by Application (2026-2031)
 Table 70. Elanco Company Information
 Table 71. Elanco Description and Business Overview
 Table 72. Elanco Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Elanco Vaccines and Parasiticides for Pet Product
 Table 74. Elanco Recent Developments/Updates
 Table 75. VCA Animal Hospitals Company Information
 Table 76. VCA Animal Hospitals Description and Business Overview
 Table 77. VCA Animal Hospitals Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. VCA Animal Hospitals Vaccines and Parasiticides for Pet Product
 Table 79. VCA Animal Hospitals Recent Developments/Updates
 Table 80. Banfield Company Information
 Table 81. Banfield Description and Business Overview
 Table 82. Banfield Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Banfield Vaccines and Parasiticides for Pet Product
 Table 84. Banfield Recent Developments/Updates
 Table 85. CVS Group Company Information
 Table 86. CVS Group Description and Business Overview
 Table 87. CVS Group Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CVS Group Vaccines and Parasiticides for Pet Product
 Table 89. CVS Group Recent Developments/Updates
 Table 90. MedVet Company Information
 Table 91. MedVet Description and Business Overview
 Table 92. MedVet Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. MedVet Vaccines and Parasiticides for Pet Product
 Table 94. MedVet Recent Developments/Updates
 Table 95. Petco Company Information
 Table 96. Petco Description and Business Overview
 Table 97. Petco Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Petco Vaccines and Parasiticides for Pet Product
 Table 99. Petco Recent Developments/Updates
 Table 100. Puppy Town Animal Hospital Company Information
 Table 101. Puppy Town Animal Hospital Description and Business Overview
 Table 102. Puppy Town Animal Hospital Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Puppy Town Animal Hospital Vaccines and Parasiticides for Pet Product
 Table 104. Puppy Town Animal Hospital Recent Developments/Updates
 Table 105. PetIQ Company Information
 Table 106. PetIQ Description and Business Overview
 Table 107. PetIQ Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. PetIQ Vaccines and Parasiticides for Pet Product
 Table 109. PetIQ Recent Developments/Updates
 Table 110. Beloved Pet Hospital Company Information
 Table 111. Beloved Pet Hospital Description and Business Overview
 Table 112. Beloved Pet Hospital Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Beloved Pet Hospital Vaccines and Parasiticides for Pet Product
 Table 114. Beloved Pet Hospital Recent Developments/Updates
 Table 115. Vegreville Veterinary Clinic Company Information
 Table 116. Vegreville Veterinary Clinic Description and Business Overview
 Table 117. Vegreville Veterinary Clinic Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Vegreville Veterinary Clinic Vaccines and Parasiticides for Pet Product
 Table 119. Vegreville Veterinary Clinic Recent Developments/Updates
 Table 120. Boehringer Ingelheim Company Information
 Table 121. Boehringer Ingelheim Description and Business Overview
 Table 122. Boehringer Ingelheim Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Boehringer Ingelheim Vaccines and Parasiticides for Pet Product
 Table 124. Boehringer Ingelheim Recent Developments/Updates
 Table 125. Zoetis Company Information
 Table 126. Zoetis Description and Business Overview
 Table 127. Zoetis Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Zoetis Vaccines and Parasiticides for Pet Product
 Table 129. Zoetis Recent Developments/Updates
 Table 130. Bayer Company Information
 Table 131. Bayer Description and Business Overview
 Table 132. Bayer Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Bayer Vaccines and Parasiticides for Pet Product
 Table 134. Bayer Recent Developments/Updates
 Table 135. Merck Company Information
 Table 136. Merck Description and Business Overview
 Table 137. Merck Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Merck Vaccines and Parasiticides for Pet Product
 Table 139. Merck Recent Developments/Updates
 Table 140. Vetoquinol Company Information
 Table 141. Vetoquinol Description and Business Overview
 Table 142. Vetoquinol Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Vetoquinol Vaccines and Parasiticides for Pet Product
 Table 144. Vetoquinol Recent Developments/Updates
 Table 145. Bimeda Animal Health Company Information
 Table 146. Bimeda Animal Health Description and Business Overview
 Table 147. Bimeda Animal Health Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Bimeda Animal Health Vaccines and Parasiticides for Pet Product
 Table 149. Bimeda Animal Health Recent Developments/Updates
 Table 150. Virbac Company Information
 Table 151. Virbac Description and Business Overview
 Table 152. Virbac Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Virbac Vaccines and Parasiticides for Pet Product
 Table 154. Virbac Recent Developments/Updates
 Table 155. Hvsen Biotechnology Company Information
 Table 156. Hvsen Biotechnology Description and Business Overview
 Table 157. Hvsen Biotechnology Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Hvsen Biotechnology Vaccines and Parasiticides for Pet Product
 Table 159. Hvsen Biotechnology Recent Developments/Updates
 Table 160. Ceva Corporate Company Information
 Table 161. Ceva Corporate Description and Business Overview
 Table 162. Ceva Corporate Vaccines and Parasiticides for Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Ceva Corporate Vaccines and Parasiticides for Pet Product
 Table 164. Ceva Corporate Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Vaccines and Parasiticides for Pet Distributors List
 Table 168. Vaccines and Parasiticides for Pet Customers List
 Table 169. Vaccines and Parasiticides for Pet Market Trends
 Table 170. Vaccines and Parasiticides for Pet Market Drivers
 Table 171. Vaccines and Parasiticides for Pet Market Challenges
 Table 172. Vaccines and Parasiticides for Pet Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaccines and Parasiticides for Pet
 Figure 2. Global Vaccines and Parasiticides for Pet Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccines and Parasiticides for Pet Market Share by Type: 2024 & 2031
 Figure 4. Parasiticides Product Picture
 Figure 5. Vaccines Product Picture
 Figure 6. Global Vaccines and Parasiticides for Pet Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Vaccines and Parasiticides for Pet Market Share by Application: 2024 & 2031
 Figure 8. Dog
 Figure 9. Cat
 Figure 10. Other
 Figure 11. Global Vaccines and Parasiticides for Pet Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Vaccines and Parasiticides for Pet Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Vaccines and Parasiticides for Pet Sales (2020-2031) & (K Units)
 Figure 14. Global Vaccines and Parasiticides for Pet Average Price (US$/Unit) & (2020-2031)
 Figure 15. Vaccines and Parasiticides for Pet Report Years Considered
 Figure 16. Vaccines and Parasiticides for Pet Sales Share by Manufacturers in 2024
 Figure 17. Global Vaccines and Parasiticides for Pet Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Vaccines and Parasiticides for Pet Players: Market Share by Revenue in Vaccines and Parasiticides for Pet in 2024
 Figure 19. Vaccines and Parasiticides for Pet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Vaccines and Parasiticides for Pet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Vaccines and Parasiticides for Pet Sales Market Share by Country (2020-2031)
 Figure 22. North America Vaccines and Parasiticides for Pet Revenue Market Share by Country (2020-2031)
 Figure 23. United States Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Vaccines and Parasiticides for Pet Sales Market Share by Country (2020-2031)
 Figure 26. Europe Vaccines and Parasiticides for Pet Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Vaccines and Parasiticides for Pet Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Vaccines and Parasiticides for Pet Revenue Market Share by Region (2020-2031)
 Figure 34. China Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Vaccines and Parasiticides for Pet Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Vaccines and Parasiticides for Pet Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Vaccines and Parasiticides for Pet Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Vaccines and Parasiticides for Pet Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Vaccines and Parasiticides for Pet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Vaccines and Parasiticides for Pet by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Vaccines and Parasiticides for Pet by Type (2020-2031)
 Figure 53. Global Vaccines and Parasiticides for Pet Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Vaccines and Parasiticides for Pet by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Vaccines and Parasiticides for Pet by Application (2020-2031)
 Figure 56. Global Vaccines and Parasiticides for Pet Price (US$/Unit) by Application (2020-2031)
 Figure 57. Vaccines and Parasiticides for Pet Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS